{"id":"W2966319593","doi":"10.1136/jnnp-2019-anzan.49","title":"056 Efficacy and safety of the Bruton’s tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis over 48 weeks: a randomized, placebo-controlled, phase 2 study","year":2019,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital; NeuroRx Research (Canada); University of Toronto","funders":"","keywords":"Placebo; Medicine; Clinical endpoint; Internal medicine; Gastroenterology; Randomized controlled trial; Adverse effect; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001849261,0.001293053,0.002295818,0.0004096557,0.000359907,0.0007815668,0.0006127566,0.001661152,0.005433688],"category_scores_gemma":[0.0009305483,0.0006282632,0.001465488,0.0002717574,0.0007382885,0.0007641118,0.0002805112,0.001784383,0.001026061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005354558,"about_ca_system_score_gemma":0.0007683376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004330719,"about_ca_topic_score_gemma":0.001062597,"domain_scores_codex":[0.9992877,0.0003974577,0.00004275968,0.000114677,0.00006840424,0.00008906726],"domain_scores_gemma":[0.999419,0.0001346135,0.0001439191,0.00004522649,0.00005066228,0.0002066756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.942739,0.01531777,0.001077596,0.0004241319,0.0006170518,0.00006570202,0.00005287196,0.0003328196,0.01393359,0.00006601896,0.0006971618,0.02467631],"study_design_scores_gemma":[0.7941265,0.1987345,0.004543623,0.00002169752,0.000281898,0.00006001507,0.00001303772,0.0003870097,0.001099299,0.00006620712,0.0006507685,0.0000153912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927934,0.002436615,0.000370018,0.0002549987,0.0001508848,0.001849579,0.000713645,0.00007369585,0.001357183],"genre_scores_gemma":[0.9928904,0.001111454,0.001004707,0.0004981653,0.0002495976,0.001631663,0.0008860917,0.00001381144,0.00171412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005433688,"threshold_uncertainty_score":0.01817745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01080856343688802,"score_gpt":0.2572244751140013,"score_spread":0.2464159116771132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}